Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Reach CFO makes share sale

(Sharecast News) - Publishing company Reach revealed on Friday that chief financial officer Darren Fisher had disposed of 31,638 ordinary shares in the London-listed firm. Fisher, who made the sale to cover withholding tax and other deductions arising from the exercise of his LTIP award, sold the shares at an average price of 78.30p each, for a total value of £24,772.55.

As of 1600 BST, Reach shares were up 1.81% at 78.80p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Kerry Group 'a' Shares (cdi) (KYGA) Director name: Kerr ,Michael Amount purchased: 10,000 @ 79.62 Value: 796,200.03

Getbusy (GETB) Director name: Rabie,Daniel Adam Amount purchased: 235,000 @ 65.00p Value: £152,749.99

Merit Group (MRIT) Director name: Conlon,Con Amount purchased: 20,750 @ 73.00p Value: £15,147.50

Top Director Sells

Reach (RCH) Director name: Fisher,Darren Amount sold: 31,638 @ 78.30p Value: £24,772.55

Share this article

Related Sharecast Articles

Director dealings: Essentra CEO raises stake
(Sharecast News) - Essentra revealed on Wednesday that chief execuitve Scott Fawcett had acquired 17,483 ordinary shares in the FTSE 250-listed hardware manufacturer.
Director dealings: AB Dynamics CEO snaps up shares
(Sharecast News) - AB Dynamics revealed on Tuesday that chief executive Sarah Matthews-DeMers had acquired 2,000 ordinar shares in the AIM-listed automotive testing and development solution supplier.
Director dealings: Bioventix chairman raises stake
(Sharecast News) - Bioventix revealed on Monday that chairman Ian Nicholson had acquired 1,000 ordinary shares in the AIM-listed biotechnology firm.
Director dealings: Bioventix chairman raises stake
(Sharecast News) - Bioventix revealed on Monday that chairman Ian Nicholson had acquired 1,000 ordinary shares in the AIM-listed biotechnology firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.